All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2005-000615-99 | Freiburger ZNS-NHL Studie Therapie für Patienten mit primären Non-Hodgkin Lymphomen des ZNS – Sequentielle Hochdosis-Chemotherapie mit autologer peripherer Blutstammzelltransplantation | 2015-03-02 | due-trials |
Reported results | 2005-000663-26 | Immunsuppressive Therapy in Duchenne Muscular Dystrophy | 2008-04-30 | due-trials |
Reported results | 2005-003812-31 | Niaspan in combination with fluvastatin compared to fluvastatin-monotherapy fpr patients with metabolic syndrome | 2009-02-27 | due-trials |
Reported results | 2006-000222-31 | Vergleich einer strukturierten störungsspezifischen Gruppenpsychotherapie plus Placebo oder Methylphenidat versus einer psychiatrischen Beratung plus Placebo oder Methylphenidat bei ADHS im Erwachsen... | 2013-03-07 | due-trials |
Reported results | 2006-002207-13 | Ziprasidone for severe conduct and other disruptive behavior disorders in children and adolescents – a placebo controlled, randomized, double blind clinical trial | 2009-12-21 | due-trials |
Reported results | 2006-005906-30 | The effect of Ezetimibe 10 mg, Simvastatin 20 mg and the Combination of Simvastatin 20 mg plus 10 mg Ezetimibe on LDL-Subfractions in patients with Type 2 Diabetes (Die Wirkung einer Monotherapie mit ... | 2010-05-19 | due-trials |
Exempt | 2007-001892-12 | Everolimus and mycophenolate as GvHD-prophylaxis in the allogenous blood stem cell transplantation (Everolimus und Mycophenolsäure als GvHD-Prophylaxe in der allogenen Blutstammzelltransplantation) | not-yet-due | |
Ongoing | 2007-004990-24 | Comparison of the concentrations of the antibiotic compound Daptomycin in serum, cartilage-, muscle and subcutaneous tissue after a preoperative intravenous administration (Klinische Studie zum Ver... | not-yet-due | |
Reported results | 2007-006516-31 | Triple arm, prospective-randomised multi centre study phase IV to evaluate calcineurin inhibitor reduced, steroid free immunosuppression after renal transplantation in low-risk patients (HARMONY-Study... | 2014-07-31 | due-trials |
Ongoing | 2007-006914-41 | Differential responses to Cognitive Behavioural Analysis System of Psychotherapy (CBASP) versus escitalopram in chronic major depression with and without early trauma | not-yet-due | |
Reported results Terminated | 2008-001833-87 | Use of Palifermin to reduce the duration, frequency and severity of oral mucositis after high dose therapy with BEAM and autologous peripheral blood stem cell transplantation in patients with malign l... | 2011-06-30 | due-trials |
Reported results | 2008-007645-31 | Freiburger Studie zur Behandlung von Primären ZNS-Lymphomen bei Patienten über 65 Jahre: Methotrexat-basierte Chemo-Immuntherapie mit anschließender Erhaltungstherapie - PRIMAIN-Studie - | 2015-03-02 | due-trials |
Reported results | 2009-009916-33 | Prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic ac... | 2016-07-13 | due-trials |
Ongoing | 2009-012432-32 | RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE AND HIGH-DOSE CYTARABINE WITH OR WITHOUT THIOTEPA, AND WITH OR WITHOUT RITUXIMAB, FOLLOWED BY BRAIN IRRADIATION vs. HIGH-D... | not-yet-due | |
Reported results | 2010-018624-20 | Tolerance of virucidal alcohol-based hand rubs - healthy volunteer trial | 2011-01-17 | due-trials |
Completed, but no date | 2010-020956-69 | Effekte von Oxytocin bei Patientinnen und Patienten mit Borderline-Persönlichkeitsstörung | bad-data | |
Not reported | 2010-022511-18 | Behavioral effects and neural correlates of oxytocin on social attention [Verhaltenseffekte und neuronales Korrelat von Oxytocin im Kontext sozialer Aufmerksamkeit] | 2019-12-31 | due-trials |
Exempt, with results | 2011-000388-28 | Safety of Vorinostat in combination with Bortezomib, Doxorubicin and Dexamethasone (VBDD) in patients with refractory or relapsed multiple myeloma | 2015-12-01 | not-yet-due |
Ongoing | 2012-003281-40 | Efficacy of gencydo nasal spray on early nasal response after allergen exposition in patients with grass pollen allergy: a randomized, placebo controlled cross over study Wirksamkeit von Gencydo Na... | not-yet-due | |
Reported results | 2012-005414-18 | Thiotepa- Fludarabine- Treosulfan (TFT) conditioning for 2nd allogeneic PBSCT from a different unrelated donor in patients with AML relapsing from prior allogeneic HCT Konditionierung mit Thiotepa-... | 2020-04-17 | due-trials |
Reported results Terminated | 2013-000077-68 | Imatinib continuation versus Nilotinib 300 mg twice daily in patients with chronic myeloid leukemia (CML) in chronic phase and major molecular response (MMR) without molecular response ≥ 4.5 log (MR4.... | 2018-09-18 | due-trials |
Reported results | 2013-002515-10 | Treatment of Optic Neuritis with Erythropoietin: a randomised, double-blind, placebo-controlled trial Behandlung der Optikusneuritis mit Erythropoietin | 2019-11-26 | due-trials |
Ongoing | 2013-002539-13 | Multicenter randomized double masked parallel design exploratory study to assess safety and efficacy of two different doses of intravitreal anti-VEGF treatment with ranibizumab (0.12 mg vs. 0.20 mg) i... | not-yet-due | |
Not reported | 2013-004879-13 | α-RT; Phase II open-label study to evaluate the efficacy and safety of Radium-223 dichloride in combination with external beam radiotherapy (EBRT) vs. EBRT alone in the treatment of advanced castrati... | 2017-05-30 | due-trials |
Reported results Terminated | 2014-000180-41 | Carriage of 3GCREB in patients at risk for relapsing infection: randomized controlled trial of intestinal decolonization with colistin plus rifaximin. Infektionsprävention durch intestinale Dekolon... | 2016-12-02 | due-trials |
Ongoing | 2014-001148-40 | Pharmacodynamic comparison of thienopyridine loading strategies in patients undergoing elective coronary stenting | not-yet-due | |
Ongoing | 2014-001541-24 | Neuroenhancement of Interpersonal Psychotherapy in Major Depression Augmentation von Interpersoneller Psychotherapie durch D-Cycloserin | not-yet-due | |
Reported results Terminated | 2014-004267-20 | Multicenter, randomized Phase 2 Trial to determine the Response Rate of Ruxolitinib and Best Available Treatment (BAT) versus BAT in Steroid-refractory acute Graft-versus-Host Disease (aGvHD) Mult... | 2019-11-15 | due-trials |
Completed, but no date, and reported results | 2014-005069-60 | R-CPOP as first line therapy for elderly patients with DLBCL and for patients with limited cardiac function with DLBCL | bad-data | |
Reported results | 2014-005473-36 | Modeling of lipoprotein in patients with familial hypercholesterolemia compared to healthy subjects Modelling der Lipoproteine bei Patienten mit familiärer Hypercholesterinämie im Vergleich zu gesu... | 2020-02-05 | due-trials |
Reported results | 2015-002491-24 | Safety of Abatacept in patients with interstitial lung disease and common variable immunodeficiency (CVID) and related disease Sicherheit von Abatacept bei der Behandlung von interstitiellen Lungen... | 2018-09-26 | due-trials |
Reported results | 2015-003369-27 | A Phase I-IIa trial on low-dose IL-2 (Aldesleukin) treatment for immunological dysregulation in common variable immunodeficiency (CVID) Phase I-IIA Studie zu niedrig-dosiertem IL-2 (Aldesleukin) i... | 2018-06-05 | due-trials |
Reported results | 2015-003670-32 | A dual-center prospective phase I/II trial to establish safety, tolerability and to obtain first data on efficacy of losartan in children with recessive dystrophic epidermolysis bullosa (RDEB) Eine... | 2021-02-12 | due-trials |
Ongoing | 2015-005071-25 | Pharmacodynamic comparison of different oral P2Y12-receptor inhibitor loading strategies for transitioning from cangrelor in patients undergoing coronary stenting | not-yet-due | |
Not reported | 2015-005416-15 | An open label phase II study of Sirolimus in patients with segmental overgrowth syndrome | 2023-07-19 | due-trials |
Reported results | 2016-000214-30 | Empagliflozin and its effect on heart failure in type 2 diabetes Wirkung von Empagliflozin auf Herzinsuffizienz in Patienten mit Diabetes mellitus Typ 2 | 2020-11-19 | due-trials |
Reported results | 2016-001628-72 | Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients Altersadaptierte Hochdosistherapie gefolgt von autologer Stammzelltransplant... | 2021-12-27 | due-trials |
Reported results | 2016-003360-39 | Safety and efficacy of Abatacept in patients with treatment-resistant sarcoidosis Sicherheit und Wirksamkeit von Abatacept bei Patienten mit behandlungsresistenter Sarkoidose | 2021-02-15 | due-trials |
Completed, but no date, and reported results | 2016-003551-30 | Modeling of the impact of a PCSK9 inhibition on lipoproteins in patients with dyslipidemia Modelling der Auswirkung einer PCSK9 Inhibition auf die Lipoproteine bei Patienten mit Dyslipidämie | bad-data | |
Ongoing | 2017-000868-15 | Stereotactic Cisternal Lavage in Patients with Aneurysmal Subarachnoid Hemorrhage with Urokinase and Nimodipine for the Prevention of Secondary Brain Injury. A Randomized Controlled Trial. Stereota... | not-yet-due | |
Exempt | 2017-002194-18 | Phase 1/2 Trial to determine the Response Rate of Nivolumab in Acute Myeloid Leukemia (AML) relapse after Allogeneic Hematopoietic Cell Transplantation (allo-HCT) | 2022-11-24 | not-yet-due |
Completed, report not yet due | 2017-004219-37 | A randomized, prospective, multicenter, controlled and double-blinded Phase II Clinical Trial to evaluate the influence of inhaled Aviptadil on Cough and Quality of Life in Sarcoidosis patients | 2024-09-03 | not-yet-due |
Ongoing | 2017-004570-34 | Phase II, Open-label, Study in Patients with anaplastic (ATC) or poorly differentiated thyroid carcinomas (PDTC) to investigate the Clinical Efficacy and Safety of the Combination Therapy of Lenvatini... | not-yet-due | |
Ongoing | 2017-004729-34 | Effects of transdermal estrogen on Bone Mass in adolescent female patients with Anorexia nervosa (AN) – a placebo-controlled, double-blind, randomized, interventional study „Wirkung von transdermal... | not-yet-due | |
Not reported | 2018-000017-20 | Antiplatelet effect of acetylsalicylic acid in patients after cardiac surgery: Impact of dipyrone (metamizole) Postoperativer thrombozytenhemmender Effekt von Acetylsalicylsäure bei herzchirurgis... | 2023-07-12 | due-trials |
Not reported | 2019-000972-40 | Safety and Efficacy of abatacept (s.c.) in patients with CTLA4 insufficiency or LRBA deficiency Sicherheit und Wirksamkeit von Abatacept (s.c.) in Patienten mit CTLA4 Insuffizi-enz oder LRBA Defizi... | 2023-06-28 | due-trials |
Not reported Terminated | 2020-000382-16 | Efficacy of daratumumab (Dara) retreatment using a histone deacetylase-inhibitor (HDACi: panobinostat) as a Dara-longevity-inducing, epigenetic agent in combination with bortezomib-dexamethasone as ... | 2022-06-01 | due-trials |
Other | 2020-001181-10 | Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients – a randomi... | not-yet-due | |
Reported results Terminated | 2020-001408-41 | A prospective, randomized, double blinded placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia | 2020-08-31 | due-trials |
Other | 2020-001575-33 | Low-dose AtropIne for Myopia control in children Niedrig dosiertes Atropin zur Myopie-Kontrolle bei Kindern | not-yet-due | |
Other | 2021-001291-42 | Radiotherapy in combination with pembrolizumab in patients with PSA persistence or biochemical recurrence after radical prostatectomy due to prostate cancer Behandlung von Patienten mit einem persi... | not-yet-due | |
Exempt | 2021-002073-26 | Phase 1/2 Trial to determine the safety and efficacy of Extracorporeal photopheresis as treatment for steroid-refractory immune related adverse events after immune checkpoint inhibitor therapy Phas... | not-yet-due |